Colombian consensus of experts on evidence-informed recommendations for the prevention, diagnosis, and management of SARS-CoV-2 / COVID-19 infection in pediatric patients with chronic kidney disease or acute kidney injury associated with COVID-19
PDF (Español)


renal disease
kidney disease

How to Cite

Baquero R, Yomayusa N, González C, Yama E, Vargas JG, Rico J, Ariza A, Aroca G, Ramírez R, Chacón K, Torres R, Robayo A, Meza Martínez AI, Calderón Ortiz AM, Zapata Chica CA, Morales Contreras CL, Ochoa García CL, Pinto Bernal C, Chacón Jaimes DC, Villafañe Bermúdez DR, Suárez Barajas EM, Atencia López F, Guerrero Tinoco GA, Cáceres Mosquera JA, Cárdenas Aguilera JG, González LE, Osorio Ruiz MF, Carrascal Guzmán MI, Mejía Gaviria N, Sierra Quiroz Y, Espitaleta Z, Beltrán S. Colombian consensus of experts on evidence-informed recommendations for the prevention, diagnosis, and management of SARS-CoV-2 / COVID-19 infection in pediatric patients with chronic kidney disease or acute kidney injury associated with COVID-19. Rev. Colomb. Nefrol. [Internet]. 2020 Jul. 6 [cited 2024 Jul. 18];7(Supl.2). Available from:


Introduction: The numbers of SARS-CoV-2 infection in the pediatric population are low so far. There is limited information about the behavior of SARS-CoV-2 in a pediatric patient with chronic kidney disease.

Objective: To formulate informed recommendations to the prevention, diagnosis, and management of SARS-CoV-2 infection in pediatric patients with kidney disease or acute kidney injury associated with COVID-19 in Colombia.

Methodology: A rapid systematic review was performed in Embase and Pubmed databases and scientific societies, to answer questions prioritized by clinical experts in pediatric nephrology. The quality of the evidence was evaluated with validated tools according to the type of study. The preliminary recommendations were consulted by an expert group. The agreement was defined when approval was obtained from at least 70% of the experts consulted.

Results: A response was obtained from 19 experts in pediatric nephrology in Colombia, who declared the conflict of interest before the consultation. The range of agreement for the recommendations ranged from 78.9% to 100%. The recommendations did not require a second consultation.

Conclusion: The evidence-based recommendations for the management of a patient with kidney disease and COVID-19 in the Colombian context are presented.
PDF (Español)


World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020.

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020;20(5):533–4. Available from:

Instituto Naciona de Salud (INS). Coronavirus (COVID - 2019) en Colombia. 2020.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 Feb 28;382(18):1708–20. Available from:

Chen J, Zhang ZZ, Chen YK, Long QX, Tian WG, Deng HJ, et al. The clinical and immunological features of pediatric COVID-19 patients in China. Genes Dis [Internet]. 2020; Available from:

Center for Disease Control and Prevention. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. Vol. 69, US Department of Health and Human Services/Centers for Disease Control and Prevention. 2020.

Accini Mendoza J, Beltrán N, Estrada VHN, Bolaños ER, Gómez CP, Rebolledo M CE, et al. Declaración De Consenso En Medicina Crítica Para La Atención Multidisciplinaria Del Paciente Con Sospecha O Confirmación Diagnóstica De Covid-19. Asoc Colomb Med Crítica y Cuid Intensivo. 2020;(55):1–13.

Li H, Chen K, Liu M, Xu H, Xu Q. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. J Infect [Internet]. 2020 Apr 20;S0163-4453(20)30207-3. Available from:

Instituto de Evaluación Tecnológica en Salud, Asociación colombiana de Infectología. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19. Rev Colomb infectología. 2020;24:47.

She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol [Internet]. 2020 Mar 31; Available from:

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):e20200702.

Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med [Internet]. 2020 Apr 14; Available from:

Organización Panamericana de la Salud. Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID-19 - OPS/OMS | Organización Panamericana de la Salud. 2020;19:15. Available from:

Shen Q, Wang M, Che R, Li Q, Zhou J, Wang F, et al. Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol. 2020 Apr;

Streng A, Hartmann K, Armann J, Berner R, Liese JG. COVID-19 in hospitalized children and adolescents TT - COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31.03.2020) und erste Daten aus Deutschland. Monatsschr Kinderheilkd [Internet]. 2020 Apr 21;1–12. Available from:

Cuenta de Alto Costo (CAC). Situación de la enfermedad renal crónica. 2019.

Sociedad Latinoamericana de Nefrología e Hipertensión. Recomendaciones para el manejo de pacientes portadores de enfermedad renal frente a la epidemia de coronavirus (COVID-19). 2020;(15).

Joanna Briggs Institute. The Joanna Briggs Institute Scientific Writer Handbook. 2018;29. Available from: Scientific Writer Handbook_July 2018.pdf

Wang D, Xiuli J, Feng X, Jing LY. 以对应于中线放电的癫痫性负性肌阵挛 起病的儿童癫痫电临床特点. 中华儿科杂志. 2019;57(12):179–82.

National Health Service - NHS. Clinical guide for acute kidney injury in hospitalised patients with COVID-19 outside the intensive care unit during the coronavirus pandemic. 2020;

Selewski DT, Cornell TT, Heung M, Troost JP, Ehrmann BJ, Lombel RM, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014 Oct;40(10):1481–8.

Durvasula R, Wellington T, McNamara E, Watnick S. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle. American journal of kidney diseases : the official journal of the National Kidney Foundation. United States; 2020.

Melgosa M, Madrid A, Alvárez O, Lumbreras J, Nieto F, Parada E. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. 2020;6–9.

Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr [Internet]. 2020 May 11; Available from:

Staico MF, Zaffanello M, Di Pietro G, Fanos V, Marcialis MA. The kidney in COVID-19: protagonist or figurant? Panminerva Med [Internet]. 2020; Available from:

Vijayan A. Advice for Managing Acute Kidney Injury in COVID-19 Patients. 2020;25–7.

Carlotti AP de CP, Carvalho WB de, Johnston C, Rodriguez IS, Delgado AF. COVID-19 Diagnostic and Management Protocol for Pediatric Patients. Clinics (Sao Paulo) [Internet]. 2020 Apr 17;75:e1894–e1894. Available from:

Cuenta de Alto Costo (CAC). Boletín de información técnica especializada. 2018.

The Renal Association. Stratified Risk for Prolonged Self Isolation for Adults and Children who are Receiving Immunosuppression for Disease of Their Native Kidneys. Vol. 1. 2020.

Bomback AS, Canetta PA, Ahn W, Ahmad SB, Radhakrishnan J, Appel GB. How COVID-19 Has Changed the Management of Glomerular Diseases. Clin J Am Soc Nephrol. 2020 Apr;

Ong JSM, Tosoni A, Kim Y, Kissoon N, Murthy S. Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature. Pediatr Crit Care Med [Internet]. 9000;Online Fir. Available from:

Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, et al. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA [Internet]. 2020 May 11; Available from:

Magagnoli J, Narendran S, Pereira F, Cummings T, Hardin JW, Sutton SS, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv [Internet]. 2020 Jan 1;2020.04.16.20065920. Available from:

Bessière F, Roccia H, Delinière A, Charrière R, Chevalier P, Argaud L, et al. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA Cardiol [Internet]. 2020 May 1; Available from:

Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 May;

World Health Organization (WHO). “Solidarity” clinical trial for COVID-19 treatments. 2020.

Sun D, Li H, Lu X-X, Xiao H, Ren J, Zhang F-R, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr [Internet]. 2020 Mar 19;1–9. Available from:

The National Heart, Lung and BIPCTN. Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients. N Engl J Med [Internet]. 2019 Dec 11;381(26):2529–40. Available from:

Kalantar-Zadeh K, Moore LW. Impact of Nutrition and Diet on COVID-19 Infection and Implications for Kidney Health and Kidney Disease Management. J Ren Nutr. 2020;30(3):179–81.

No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.




Download data is not yet available.